ライフサイエンスコーパス: be comparable between

1 Similarly, the LAD/LCx in vitro count ratios were comparable between 201TI and 99mTc-tetrofosmin in 1

2 sue volume and intramyocellular lipid levels were comparable between 8-wk fructose- and glucose-fed m

3 lyses showed that the FasL promoter activity was comparable between a construct that contains both si

4 udes of induction of host cytokine responses were comparable between A(H7N9) and H5N1 virus infection

5 Duration of support was comparable between ACE-I and control subjects (96 +/

6 sicular stomatitis virus single-cycle yields were comparable between adar1(-/-) and adar2(-/-) cells,

7 ngle-cycle yields and growth kinetics of PyV were comparable between adar1(-/-) and adar2(-/-) geneti

8 s, the median number of positive lymph nodes was comparable between ADC and SRC < 50% (4 vs 5, P = 0.

9 f the gp120- and V1V2-specific IgG responses were comparable between adults and infants immunized wit

10 ical full-length amyloid-beta42 accumulation was comparable between Alzheimer's disease and pathologi

11 risk-standardized unplanned hospital visits were comparable between ambulatory surgery centers and h

12 he rod- and cone-mediated ERG a- and b-waves were comparable between Ames waltzer mutants and heteroz

13 Levels of all cytokines were comparable between animals with rapid (survival, <2

14 e-carboplatin; grade 3 to 4 thrombocytopenia was comparable between arms and anemia was higher in the

15 e of non-VZV-related herpes viral infections was comparable between arms.

16 sful in avoiding referral bias (participants were comparable between arms on important characteristic

17 Adverse events were comparable between arms, except for a lower inciden

18 Tolerability profiles were comparable between arms.

19 cteristics and mean tacrolimus trough levels were comparable between arms.

20 recurrent HBV infection posttransplantation were comparable between Asians and whites.

21 etween SL 2.0 and 2.3 microm (Delta pCa(50)) was comparable between ATP and dATP, but reduced with lo

22 Image quality was comparable between awake and anesthetized conditions

23 On the other hand, expression levels of HA were comparable between B16-F1 and B16-F10 melanoma cell

24 take of eGFP labelled EVs in recipient cells was comparable between BE-SEC and UC samples.

25 Myeloid and platelet engraftment was comparable between bone marrow and PBSC recipients (

26 Stress myocardial flow was comparable between both groups (2.3 +/- 0.9 vs. 2.3

27 Results Engraftment was comparable between both groups.

28 Neointimal thickness and inflammatory scores were comparable between both devices at 180 days.

29 O2 production and body temperature, however, were comparable between both groups of mice.

30 manifestations, as well as disease activity, were comparable between both groups.

31 rn size, concomitant injuries, and mortality were comparable between both groups.

32 However, mean ESV and EDV at stress and rest were comparable between both subgroups (p = NS).

33 of tumor control in the breast and survival were comparable between BRCA1/2 carriers and controls at

34 At the same time point, binary restenosis was comparable between BVS and DES (7.8% versus 8.9%; P=

35 Odds ratios were comparable between Cache County and AlzGene.org whe

36 The prevalence of metabolic syndrome was comparable between cases (17%) and controls (9%) (P

37 es of CD27(-)CD28(-) cells or CD57(+) cells) were comparable between cases and controls.

38 gher in cases, CMV-specific T-cell responses were comparable between cases and controls.

39 lecular pattern (MAMP) content of microbiota were comparable between CD and HC, but a sub-population

40 madelta-17 and gammadelta-IFNgamma effectors were comparable between CD28(+/+) and CD28(-/-) mice.

41 Baseline and clinical parameters were comparable between children receiving LGG and place

42 up Ag, measured by fluid phase endocytosis, was comparable between CIITA(-/-) and control DC.

43 , CEC-normalized sorption for most compounds was comparable between clays and soil organic matter.

44 Variant allele fractions were comparable between clonal ICUS (CCUS) and MDS as we

45 3-CGA concentrations and pH were comparable between cold and hot brews.

46 Progression of GA area is comparable between color photographs and FAF images,

47 hypothalamic bioamine indices were found to be comparable between control and Obx groups.

48 f NBN and ATM recruited to the sites of DSBs was comparable between control cells and those expressin

49 Post-HCT scores were comparable between controls and autologous and redu

50 lasma arginine and citrulline concentrations were comparable between COPD patients and controls, whol

51 Median MBF at rest was comparable between CZT and PET (0.89 [interquartile

52 At week 2, transduction efficiency was comparable between d5 and d6 transduced CR and CNR c

53 increase in RSNA induced by insulin and CRF was comparable between db/db and control mice.

54 Posttransplantation kidney function is comparable between DCD and DBD kidney transplantation

55 In multicentric disease, outcomes are comparable between debulking surgery alone, immunoch

56 Frequency of drug-related adverse events was comparable between deferasirox (35.4%) and deferoxam

57 In contrast, monocyte and DC recruitment was comparable between DEP-exposed wild-type and CCR5 kn

58 aracterization of phenotypes so that results are comparable between different laboratories and phenot

59 cted dose, the levels of gadolinium measured were comparable between different doses, indicating that

60 ber and mean duration of places of residence were comparable between direct and proxy respondents, su

61 he growing leaf, while GRF4 and GRF10 levels were comparable between division zone and expansion zone

62 Kidney graft survival is comparable between donation after cardiac death (DCD)

63 S1P-induced Akt and ERK1/2 activation were comparable between ECs of different in vitro ages;

64 asured as avidity and in vitro opsonization, were comparable between elderly and young subjects over

65 the allelic effects for most of the 10 SNPs were comparable between Europeans and Asians.

66 Rates of PTMS were comparable between EVR-containing and TAC control r

67 The central corneal thickness was comparable between fellow-eye primary and secondary

68 Node-positive primary was comparable between FOLFOX and 5-FU but lower in the

69 ion, immune recovery and development of ADEs were comparable between foreign-born and US-born patient

70 eletal reorganization, and its TrkB receptor were comparable between genotypes.

71 s of leading edge protrusion and retraction, were comparable between genotypes; however, ARPC3(-/-) c

72 though proliferation of isolated fibroblasts was comparable between GPA and controls, GPA samples sho

73 city, reactogenicity, and safety appeared to be comparable between groups.

74 The incidence of treatment failure was comparable between groups after 12 months: 57.5% in

75 of adverse remodeling; however, infarct size was comparable between groups suggesting that the benefi

76 OXPHOS capacity was comparable between groups when complex I- and comple

77 Freedom from death was comparable between groups with 1-, 2-, and 5-year su

78 Although LV ejection fraction was comparable between groups, longitudinal peak was red

79 Whereas whole-body fat mass was comparable between groups, persons with OLD had incr

80 nsulin levels, endogenous glucose production was comparable between groups, suggesting lower hepatic

81 Safety generally was comparable between groups.

82 Except for HNC, health care utilization was comparable between groups.

83 diastolic dysfunction; however, infarct size was comparable between groups.

84 Mean flow rate was comparable between groups.

85 Meissner corpuscles and dermal nerve bundles were comparable between groups (P>0.07).

86 Mechanical and thermal pain thresholds were comparable between groups (P>0.13).

87 risk (5%).Most recipient and donor features were comparable between groups A and B.The 1- and 3-year

88 in fractional anisotropy within these tracts were comparable between groups across the age span.

89 Bowel screening examinations were comparable between groups throughout.

90 Rates of HBeAg loss and HBeAg seroconversion were comparable between groups, whereas the rate of alan

91 0 days after the last manipulation, LC rates were comparable between groups.

92 postoperative morbidity and mortality rates were comparable between groups.

93 l resistance and incidence of adverse events were comparable between groups.

94 aling complications and other adverse events were comparable between groups.

95 , major infections, and resource utilization were comparable between groups.

96 Histological findings were comparable between groups.

97 Weight and sex were comparable between groups.

98 Adverse events were comparable between groups.

99 Duration and severity of disease were comparable between groups.

100 Safety parameters were comparable between groups.

101 complication rates and BPVA after treatment were comparable between groups.

102 tomach upset and headache, yet dropout rates were comparable between groups.

103 se events and dropouts due to adverse events were comparable between groups.

104 g both uncovered and malapposed at follow-up were comparable between groups.

105 , rates of surgery and moderate-to-severe MR were comparable between groups.

106 Adverse events were comparable between groups; 16.1% of rituximab and 1

107 nts of the hepatic p85 subunit of PI3-kinase were comparable between HCV-infected and non-HCV-infecte

108 2 mumol/g vs. 0.6 +/- 0.3 mumol/g; P = 0.52) were comparable between healthy subjects and T1DM patien

109 ecific superenhancers, and global aneuploidy were comparable between high- and low-quality lines, abe

110 ses to long-term lamivudine-containing HAART were comparable between HIV-infected patients with HBV g

111 buffers, the time course of ICa inactivation was comparable between human TLE and kindled rat granule

112 Although Th9 and Th17 levels are comparable between infected TGF-betaRII DN and wild-

113 tage of cells in each round of cell division are comparable between Jak3-deficent and wild-type T cel

114 he TCR-interacting surface of class I, which was comparable between K(b) and K(bW9).

115 els of IL-6, MCP-1, IFN-gamma, and TNF-alpha were comparable between L. monocytogenes-infected AhR(-/

116 mitted per unit dry weight of plant material is comparable between laboratory enclosure measurements

117 Potencies and effects were comparable between LCLs of two genetically unrelate

118 density of macrophages in the fatty streaks was comparable between LDLR-/- P/E+/+ and LDLR-/- P/E-/-

119 an] vs 55 seconds +/- 3, P < .001), and time was comparable between magnetically assisted and standar

120 Sensitivity was comparable between marrow aspirate and biopsy.

121 ent and choline acetyltransferase expression were comparable between MD and wild-type rats.

122 This homeostatic turnover was comparable between memory CD8 T cells of different v

123 cy and safety of the potent P2Y12 inhibitors were comparable between men and women.

124 Functional outcomes were comparable between men and women.

125 identification of influenza A virus subtypes were comparable between methods.

126 ulating glutamate release onto these neurons were comparable between mKat-2-/- and WT mice.

127 allbladder, pancreas, spleen, and kidney may be comparable between MR systems from different vendors

128 infected rats, although brain fungal burdens were comparable between mucoid variant- and smooth paren

129 percentage of oscillating lipid metabolites was comparable between muscle tissue and cultured myotub

130 Substrate uptake and surface expression were comparable between mutant and WT SERTs.

131 morphology, photopic vision-guided behaviour is comparable between normal and cone ERG(absent) RPGRIP

132 EGJ opening pressure and opening diameter were comparable between normal subjects and fundoplicati

133 Baseline any type HPV prevalence was comparable between obese and nonobese women (18.7% v

134 ion, movement is directionally biased, speed is comparable between origins, and cell growth can accou

135 progression, CXCR5 expression, and migration were comparable between OX40L(+/+) and OX40L(-/-) mice i

136 The conventional HRV parameters were comparable between PA and EH patients.

137 MS4A1 gene expression levels in PBMC were comparable between patient groups at all timepoints

138 Outcomes are comparable between patients with both types after ad

139 Induction of cytokine-induced SH2 protein was comparable between patients and volunteers, whereas

140 While in-hospital mortality was comparable between patients with atypical and typica

141 ocleidomastoid and tibialis anterior muscles were comparable between patients and controls.

142 es for systemically administered antibiotics were comparable between patients receiving selective dec

143 files and expected operative mortality rates were comparable between patients who underwent surgery b

144 Rates of SVR were comparable between patients whose anemia was manage

145 Responses were comparable between patients with euvolemia and thos

146 Pharmacokinetics were comparable between patients with sarcoma and those

147 The incidence of adverse events was comparable between penciclovir and placebo groups.

148 sponse frequency (17/26 donors) and strength were comparable between Phl p 12 and Phl p 1.

149 Plasma IL-6, IL-8, and IL-10 concentrations were comparable between PICU and floor patients, but hig

150 tranded, double-stranded, and mismatched DNA were comparable between Pol and Pol2core.

151 Dlx2(+) cells in CGEs were comparable between preterm and term pups.

152 GluR1-GluR4 expressions were comparable between preterm humans and rabbits with

153 Mean septal thicknesses were comparable between rabbits carrying the wild type t

154 try, angiographic and clinical presentations were comparable between randomized and registry patients

155 observed after exposure to moderate hypoxia were comparable between rho0 cells, which lack functiona

156 3; 95% confidence interval, 0.47-1.85) risks were comparable between rivaroxaban and VKA new users.

157 he underlined C; the amount of transcription is comparable between RNAs possessing upstream (CCA)(n)

158 percentages of the transduced nonhepatocytes were comparable between RRV and VSV-G pseudotypes and di

159 Outcomes were comparable between sensitized and control recipient

160 .04), whereas the rate of adenoma detection was comparable between sets.

161 ecreasing BP (i.e. early phase II of the VM) was comparable between sexes, but it was greater in men

162 CRT-related toxicity was comparable between SGs.

163 ere greatly reduced throughout the study and were comparable between sites treated by RP, MW, and FO

164 ell activation, proliferation, and apoptosis were comparable between SIVmnd-1- and SIVmnd-2-infected

165 and whole salivary IL-1beta and IL-6 levels were comparable between smokers and never-smokers.

166 Basal homeostatic proliferation is comparable between specific CD4(+) and CD8(+)T(M) and

167 e histological appearance of carcinomas that was comparable between specimens.

168 Running was comparable between strains and VWR reduced body weig

169 infected mice revealed that IL-12 responses were comparable between strains, but Tg mice had a marke

170 Enrollment characteristics were comparable between study groups.

171 ring early (E(SR)) and late (A(SR)) diastole were comparable between stunned and remote walls (epsilo

172 ine, small airway function (R5 -R20 and X5 ) was comparable between subjects with asymptomatic BHR an

173 or frequency, expansion, and IL-4 expression were comparable between susceptible and resistant mice.

174 sitive margin rates and residual tumor rates are comparable between the ABBI and WL bx.

175 the secretion kinetics of the mature genomes are comparable between the wild-type HBV and the mutant

176 the MRG agonist peptide, BAM15, appeared to be comparable between the BLA assay and the intracellula

177 xpression and binding affinity were found to be comparable between the parental sensitive (HUT78S) an

178 d point (death/stroke/myocardial infarction) is comparable between the 2 treatment options for diabet

179 While population-based variability is comparable between the routes, FcepsilonRI- and MRGPR

180 e dynamic range of the emission ratio change is comparable between the two pH sensors over the range

181 Mortality was comparable between the 2 groups (HR, 1.19; 95% CI, 0

182 however the final visual acuity at 6 months was comparable between the 2 groups.

183 The risk of infection was comparable between the 2 groups; however, patients w

184 of selected genes confirmed that expression was comparable between the 2 species.

185 ize (triphenyltetrazolium chloride staining) was comparable between the AB and Dil groups (29.6+/-2.9

186 umor growth rate, determined from CT images, was comparable between the animals with recurrent tumors

187 Overall rate of adverse events (AEs) was comparable between the ASA404 and placebo arms.

188 The IFN SAR structure was comparable between the BV173 leukemia cell line and

189 on of patients experiencing an adverse event was comparable between the combined guselkumab (13/20 [6

190 Favorable neurologic outcome at discharge was comparable between the cyclosporine and control grou

191 ence of rejection, graft loss, and mortality was comparable between the D+/R+ and D-/R+ groups.

192 y later time points the extent of activation was comparable between the glial cell types.

193 Isotopic glomerular filtration rate was comparable between the groups at 1 year (57+/-26 mL/

194 The incidence of adverse events was comparable between the groups, and no significant fo

195 of cartilage damage and joint cyst formation was comparable between the groups, the degree of ligamen

196 ICU stay was comparable between the groups.

197 s factor alpha (TNF-alpha)-induced apoptosis was comparable between the HeLa lines.

198 Although virus shedding was comparable between the N(752) and D(752) variants, i

199 catheter-related bloodstream infection risk was comparable between the sites.

200 Patient survival was comparable between the study groups.

201 In five studies, CBL around implants was comparable between the test and control groups.

202 mean transit time and blood volume fraction) was comparable between the three groups of animals.

203 T and HA whereas the motivation for the drug was comparable between the three groups.

204 The overall response rate was comparable between the two arms (GO, 45%; no GO, 49%

205 TTP was comparable between the two arms in treatment-naive p

206 ion and that the magnitude of the modulation was comparable between the two brain areas.

207 Antibiotic administration at 1 and 3 hours was comparable between the two cohorts, but initial anti

208 Proportion of noncancer deaths was comparable between the two cohorts.

209 blood blasts (27% v 33%); risk distribution was comparable between the two groups.

210 l function at baseline and time of screening was comparable between the two groups.

211 that resulted in study drug discontinuation was comparable between the two groups.

212 relative seizure susceptibility of a strain was comparable between the two laboratories, suggesting

213 Although liver exposure was comparable between the two mouse strains (despite th

214 ime course of pulmonary markers in survivors was comparable between the two serogroups.

215 t required intervention after trabeculectomy were comparable between the 2 groups (DSAEK vs PK, all i

216 Length of stay and total hospital cost were comparable between the 2 groups (P > .05).

217 Intraoperative complications were comparable between the 2 groups except the occurren

218 9) and mortality rates (6% vs 4%, P = 0.214) were comparable between the 2 groups, patients who under

219 and severity of other adverse drug reactions were comparable between the 2 groups.

220 erior reattachment rates and PVR recurrence) were comparable between the 2 groups.

221 Postoperative pain scores were comparable between the 2 groups.

222 emophilus influenzae type b vaccine antigens were comparable between the 2 groups.

223 P = 0.03), but the 1- and 5-year DCGS rates were comparable between the 2 groups; moreover, the 1-,

224 roprotection rates, and seroconversion rates were comparable between the 2 vaccines.

225 omes (procedure, fluoroscopy, and PVI times) were comparable between the 3 arms.

226 ron, tear film status, and lid abnormalities were comparable between the 3 groups.

227 Patient demographics and baseline QOL scores were comparable between the 74-Gy and 60-Gy arms.

228 al loss since neuron-specific enolase levels were comparable between the AD groups, regardless of APO

229 Overall, the sensitivity and NPV were comparable between the assays, but the IHPV assay d

230 nd signal transducing Janus tyrosine kinases were comparable between the cells transformed by the wil

231 ANC increments after granulocyte transfusion were comparable between the cohorts with positive and ne

232 rmined 1 hour after granulocyte transfusion, were comparable between the cohorts.

233 fection efficiency in HeLa and NIH/3T3 cells were comparable between the copolymers but pHCathK(10) w

234 Rates of adverse events were comparable between the denosumab and placebo groups

235 model (a sigmoid curve with variable slope) were comparable between the early XTT and spectrophotome

236 Mean transit time and blood volume fraction were comparable between the four groups of rats.

237 along with 3-year patient and graft survival were comparable between the groups.

238 Baseline characteristics were comparable between the groups.

239 Baseline clinical characteristics were comparable between the groups.

240 Hemoglobin levels were comparable between the groups.

241 nation rates, although not protocol defined, were comparable between the intervention and comparison

242 ry attenuation values +/- standard deviation were comparable between the iodixanol 270 and iopromide

243 turbances (5% v 0%), grade 3 to 4 toxicities were comparable between the IROX and irinotecan groups,

244 activated T cell and expression of CD69/CD25 were comparable between the mutant and wild-type Jurkat

245 4%), and subacute thrombosis (0.6% vs. 1.2%) were comparable between the paclitaxel-eluting and contr

246 erm survival and freedom from reintervention were comparable between the Ross procedure and mechanica

247 activity and physical function improvements were comparable between the SC and IV abatacept-treated

248 discontinuation rates due to adverse events were comparable between the tasimelteon (3 [6%] of 52 pa

249 Types and rates of adverse events were comparable between the treatment groups.

250 Baseline characteristics were comparable between the treatment-naive and treatmen

251 Grade 3/4 toxicities were comparable between the two arms except that grade 3

252 sponse improvement, and duration of response were comparable between the two arms.

253 Adverse events were comparable between the two central venous catheter

254 ts revealed that accuracy and reaction times were comparable between the two conditions, suggesting t

255 ng primers specific to this internal control were comparable between the two devices, indicating negl

256 binding of both benzphetamine and efavirenz were comparable between the two enzymes.

257 one status, number of positive nodes, and RT were comparable between the two groups (all P >/= .08).

258 Baseline characteristics were comparable between the two groups.

259 d 3-year patient survival and renal function were comparable between the two groups.

260 umbers of resident alveolar macrophages (AM) were comparable between the two groups.

261 ty of Thoracic Surgeons risk score and eGFR, were comparable between the two groups.

262 , graft outcomes, as well as renal function, were comparable between the two induction groups.

263 The IC(50) values generated were comparable between the two methods suggesting the c

264 Although overall prevalence rates were comparable between the two methods, results varied

265 The IC(50) values were comparable between the two methods, suggesting that

266 curves in abdominal aorta and femoral artery were comparable between the two mouse strains.

267 ta and interleukin-6, and prostaglandin E(2) were comparable between the two mouse strains.

268 The patients' characteristics were comparable between the two study groups.

269 The taxonomic richness and Shannon index were comparable between the WM and MDM but were signific

270 mph nodes and the antibody response in serum were comparable between the WT and KO animals.

271 RNA available from individual cases; results were comparable between these 2 techniques.

272 ers, whereas levels of endogenous mouse CCN2 were comparable between transgenic and wild-type mice.

273 Illness-related anxiety was comparable between treatment arms at all time points

274 FSR/HFS; 90% v 66%); grade 3 to 4 toxicities were comparable between treatment arms except HFSR/HFS (

275 Adverse events were comparable between treatment groups.

276 Other adverse events were comparable between treatment groups.

277 the incidence of breakthrough bleeding alone was comparable between treatments in all cycles.

278 ontrolled trial, yet the time to pre-syncope was comparable between trials (544 +/- 130 vs. 572 +/- 1

279 we show that the frequency of recombination is comparable between Trypanosoma congolense and Trypano

280 capsules, although the normoglycemic period was comparable between two groups of rats receiving tran

281 terrater reliability of handheld dynamometry was comparable between two studies (intraclass correlati

282 ar filtration rates after 1 year and 5 years were comparable between uDCD and cDCD (1 year: uDCD, 44.

283 Antibody responses were comparable between uninfected and HIV-infected popu

284 arison to controls; by 24 hours, drug uptake was comparable between untreated and BAPTA-treated hair

285 ination (key depression treatment indicators were comparable between usual care participants managed

286 us-specific cytotoxic-T-lymphocyte responses were comparable between vaccine groups.

287 , mortality rates and LV functional recovery were comparable between valve replacement techniques.

288 Although thymic cellularity was comparable between wild type (WT) and DKO mice, CD3(

289 significant elevation in blood pressure that was comparable between wild-type and CXCL16 knockout mic

290 pression of endogenous LCMV-specific T cells was comparable between wild-type and DeltaDC mice during

291 ogold labeling for GluN2A at MF-CA3 synapses was comparable between wild-type and Neto-null mice, lab

292 growth factor (VEGF) in response to ischemia was comparable between wild-type and Notch mutant mice,

293 However, cardiac FAO rates were comparable between wild-type and ACC-DKI mice at ba

294 ription activity and p53 protein degradation were comparable between wild-type and p50-/- cells.

295 AS severity was comparable between women and men (peak aortic jet ve

296 Bcl-2 or Bcl-XL, because expression of these was comparable between WT and double knockout OTII cells

297 covery of dietary FA in the intestinal lumen was comparable between WT and KO, consistent with the su

298 he staphylococcal superantigen enterotoxin B were comparable between WT and DKO mice.

299 Levels of impairment are comparable between youths with bipolar disorder and

300 Adverse events were comparable between zirconium cyclosilicate and plac